Monaco Asset Management SAM
Source: SEC Form 13F · as of Mar 2026Monaco Asset Management SAM holds 11 biotech & pharma companies tracked by BioSniper, totaling $40.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$40.1M
| Company | Shares | Value |
|---|---|---|
| VTRSViatris Inc | 1,255,620 | $17.0M |
| RCKTRocket Pharmaceuticals Inc. | 2,058,303 | $7.4M |
| NVAXNOVAVAX INC | 697,600 | $5.7M |
| QDELQuidelOrtho Corp | 242,595 | $4.0M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 30,000 | $1.7M |
| FATEFATE THERAPEUTICS INC | 810,000 | $972K |
| GLPGGalapagos NV | 27,520 | $826K |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 225,000 | $790K |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 858,122 | $687K |
| PRQRProQR Therapeutics N.V. | 418,803 | $678K |
| QUREuniQure N.V. | 27,500 | $450K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.